Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company’s pipeline products focus on enhancing the Cologuard test’s performance characteristics and developing blood and other fluid-based tests.
Exact Sciences
Unlock to Claim this listing
Add / Modify Company
3.11
Overall Excellence Rating
Industry
Pharmaceuticals & BiotechnologyCategory
Biotechnology ResearchESG/Ethical Impact
Our Environmental Policy is embedded in our Code of Business Conduct and Ethics and applies to all our global locations. We have dedicated environmental resources that work closely with all business units and functions to establish and implement environmental programs and policies. We require all operations to maintain compliance with national, regional, and local regulations relating to the environment, such as those affecting air emissions, water purity, and waste disposal. The purpose of our wellness programs is to positively impact the mental, physical, social, and financialwell-beingofouremployeesthroughinclusiveprogrammingrootedinempathy, compassion, and trust. Consistent with our core values of integrity, teamwork, accountability, innovation, and quality, we provide a unique, best-in-class experience that is authentic and collaborative. The wellness team at Exact Sciences works hard to foster a culture of care and compassion to help our employees and communities live happy, healthy, and full lives. We recognize wellness looks different for everyone. That’s why we’re committed to supporting each employee’s unique journey toward well-being through a holistic approach that includes best- in-class programming. In response to feedback from our team members, we developed a new internal wellness platform in 2022 to make it easier for everyone to access our wellness offerings. The company invests in R&D to advance cancer diagnostics through innovative technologies. Its research efforts contribute to the development of accurate and non-invasive diagnostic tools, impacting both patient care and financial growth. We believe that conducting business ethically is critical to our near- and long- term success. Quality, integrity, accountability, innovation, and teamwork are the foundation upon which we build our reputation and our competitive excellence. Weexpecteverydirector,officer,employee,andsuppliertopracticethe highest standards of conduct in every business relationship within the company and with our customers, business partners, competitors, and the communities in which we work. Our culture and policies are designed to help employees do what is right for our business, the environment, and society.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
![](https://excellence.bestpracticeinstitute.org/wp-content/uploads/2023/09/company2.jpg)
Awards Received
2023
Revenues
2406000000
Website Traffic
Employee Rating
3.4
Customer Rating
3
Company Size
1000-5000
ESG Risk Rating
3